White Paper: The Role of Monopoly in America’s Prescription Drug Crisis | White Paper: The Role of Hospitals in America’s Health Care Crisis
Read More
Tony Romm of The Washington Post reports on the federal investigation of Facebook’s antitrust violations and quotes Sally Hubbard, director of enforcement strategy at Open Markets Institute, opposing Facebook’s talk of integrating Facebook, Instagram, and WhatsApp.
Read More
Roger Parloff reports in Yahoo! Finance about the antitrust backlash against Big Tech and credits Open Markets Institute for elevating the issue and changing the debate.
Read More
On Yahoo Finance, Roger Parloff tells the story of how America has come to a turning point in its views of antitrust. He tracks the origins of the progressive neo-Brandesian movement and how key figures have played leading roles in igniting the Big Tech antitrust backlash in Washington including Tim Wu, Barry Lynn, Lina Khan, Matt Stoller, and Luther Lowe. Parloff quotes Former FTC chair William E. Kovacic who commented: "In five years, Barry and his group have changed the debate. They’ve gone from being a largely unnoticed fringe body of commentary to being at the very center of the debate.”
Read More
This report, “The Role of Monopoly in America’s Prescription Drug Crisis,” exposes how big pharma drives up drug costs through patent monopolies, abuses of regulations, and corporate consolidation.
Read More
As Rep. Nancy Pelosi prepares for a showdown in Congress over her Lower Drug Costs Now bill, Open Markets Institute today released The Role of Monopoly in America’s Prescription Drug Crisis.
Read More
Baldwin, Florida, a town of roughly 1,600 residents west of Jacksonville, lost its last grocery store in 2018, writes Claire Kelloway. Baldwin’s store resembles other collective and community-driven efforts to combat rural food deserts, which were partly created by predatory big-box stores. It also revives a forgotten notion that government should provide open and accessible food markets, which were a central part of municipal planning and responsibility through the 19th century.
Read More
This report, published in 2019, investigates an often-overlooked factor behind high prices for medical services: the increasing corporate concentration of ownership, particularly among hospitals.
Read More
Today, the Open Markets Institute released The Role of Hospital Monopolies in America’s Health Care Crisis, which presents insights into how the astronomically high cost of health care in the United States is a result of increasing corporate concentration of hospital ownership.
Read More
In the biggest government antimonopoly case since Microsoft, Open Markets filed an amicus brief in the Ninth Circuit Court of Appeals in support of the Federal Trade Commission (FTC) in its suit against Qualcomm.
Read More
"Importing drugs won’t bring prices down significantly because it fails to address the root cause of the problem: monopoly," said Open Markets Managing Editor Michael Bluhm in a statement today.
Read More
Open Markets Food & Power researcher and reporter Claire Kelloway published an op-ed on the Washington Monthly on November 21, 2019 on how America’s biggest dairy co-op is trying to become even bigger. Kelloway writes that one critical reason dairy farms feel pressure to consolidate is because milk retailers, buyers, and, processors have spent years consolidating around them. Now, a merger between major milk monopolists threatens to deal another blow to ailing dairy farmers, and its not clear if federal enforcers will do anything to stop it.
Read More
On November 27, 2019, the Open Markets Institute filed an amicus brief in the Ninth Circuit Court of Appeals in support of the Federal Trade Commission's anti-monopoly suit against Qualcomm, the biggest government anti-monopoly case since Microsoft.
Read More
The use of digital technology in health care has enormous promise, to be sure. But The Wall Street Journal’s coverage of Google’s Project Nightingale also revealed a potential dark side to the projects. Ascension, it noted, “also hopes to mine data to identify additional tests that could be necessary or other ways in which the system could generate more revenue from patients, documents show.”
Read More
Google Could Revolutionize Health Care IT. Here’s Why It Shouldn’t, and What We Could Do Instead
Read More
David Streitfeld reports in The New York Times about the grassroots movement to stop Amazon and quotes Barry Lynn of Open Markets Institute on the Athena coalition.
Read More
Ahead of Thanksgiving, Open Markets' Food & Power reporter Claire Kelloway speaks with Bloomberg law about consolidation among poultry producers and how price fixing is only made easier for them. "Turkey, an $18 billion industry, is one of the lone proteins not subject to any publicly known federal investigation or private suit" reports Bloomberg Law "Even though many top U.S. turkey producers, such as Cargill Inc. and Tyson Foods, allegedly sought to fix prices of other foods.
Read More
Open Markets' Sandeep Vaheesan and Claire Kelloway published a piece on The American Prospect on November 21, 2019 calling for a fair labor market for food chain workers. An overwhelmingly disenfranchised immigrant workforce and corporate collusion and concentration define work in food and agriculture today, they assert. Reforming these labor markets is essential.
Read More